Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Frandsen

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2007
Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type IAndrew Wilber, Kirk J Wangensteen, Yixin Chen, et al.
Frontiers in Bioengineering and Biotechnology|September 26, 2022
Quantifying the transport of biologics across intestinal barrier models in real-time by fluorescent imagingArjen Weller, Morten B Hansen, Rodolphe Marie, et al.
British Journal of Haematology|August 19, 2011
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot studyThomas L Frandsen, Jonas Abrahamsson, Birgitte Lausen, et al.
Pediatric Blood & Cancer|May 10, 2018
Testing physical function in children undergoing intense cancer treatment-a RESPECT feasibility studyMartin K F Nielsen, Jesper F Christensen, Thomas L Frandsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 17, 1998
Effect of NCAM-transfection on growth and invasion of a human cancer cell lineK Edvardsen, E Bock, S Jirus, et al.
Pediatric Transplantation|May 19, 2022
Waitlist and posttransplant outcomes of critically ill infants awaiting heart transplantation managed without ventricular assist device supportErik L Frandsen, Katherine A Banker, Robert L Mazor, et al.
British Journal of Haematology|January 17, 2014
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocolRaheel A Raja, Kjeld Schmiegelow, Birgitte K Albertsen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 17, 2005
Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expressionPaul R Score, Lalitha R Belur, Joel L Frandsen, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2014
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activityMette Levinsen, Susanne Rosthøj, Ulrikka Nygaard, et al.
Pediatric Blood & Cancer|March 14, 2014
Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemiaMette Levinsen, Mervi Taskinen, Jonas Abrahamsson, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2007
Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type IAndrew Wilber, Kirk J Wangensteen, Yixin Chen, et al.
Frontiers in Bioengineering and Biotechnology|September 26, 2022
Quantifying the transport of biologics across intestinal barrier models in real-time by fluorescent imagingArjen Weller, Morten B Hansen, Rodolphe Marie, et al.
British Journal of Haematology|August 19, 2011
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot studyThomas L Frandsen, Jonas Abrahamsson, Birgitte Lausen, et al.
Pediatric Blood & Cancer|May 10, 2018
Testing physical function in children undergoing intense cancer treatment-a RESPECT feasibility studyMartin K F Nielsen, Jesper F Christensen, Thomas L Frandsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 17, 1998
Effect of NCAM-transfection on growth and invasion of a human cancer cell lineK Edvardsen, E Bock, S Jirus, et al.
Pediatric Transplantation|May 19, 2022
Waitlist and posttransplant outcomes of critically ill infants awaiting heart transplantation managed without ventricular assist device supportErik L Frandsen, Katherine A Banker, Robert L Mazor, et al.
British Journal of Haematology|January 17, 2014
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocolRaheel A Raja, Kjeld Schmiegelow, Birgitte K Albertsen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 17, 2005
Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expressionPaul R Score, Lalitha R Belur, Joel L Frandsen, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2014
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activityMette Levinsen, Susanne Rosthøj, Ulrikka Nygaard, et al.
Pediatric Blood & Cancer|March 14, 2014
Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemiaMette Levinsen, Mervi Taskinen, Jonas Abrahamsson, et al.
Pageof 11